Integris Medtech files DRHP, eyes ₹3,500–4,000 crore IPO
Integris Medtech files DRHP for ₹3,500–4,000 crore IPO.
Live Market Updates
Latest Financial News
Stay ahead with real-time financial news, market insights, and expert analysis from trusted sources worldwide
News Feed
1 articles
Live Market Updates
Latest Financial News
Stay ahead with real-time financial news, market insights, and expert analysis from trusted sources worldwide
positive
3h agoIntegris Medtech files DRHP, eyes ₹3,500–4,000 crore IPO
Integris Medtech, a diversified medical technology platform in India, has submitted its Draft Red Herring Prospectus (DRHP) to SEBI for an IPO. The company aims to raise between ₹3,500 and ₹4,000 crore, including a fresh issue portion. Backed by private equity firm Everstone, Integris plans to use proceeds to expand capacity, strengthen R&D and scale its distribution network. The move marks one of the more ambitious healthcare technology IPOs in recent times.
positive
3h agoIntegris Medtech files DRHP, eyes ₹3,500–4,000 crore IPO
Integris Medtech, a diversified medical technology platform in India, has submitted its Draft Red Herring Prospectus (DRHP) to SEBI for an IPO. The company aims to raise between ₹3,500 and ₹4,000 crore, including a fresh issue portion. Backed by private equity firm Everstone, Integris plans to use proceeds to expand capacity, strengthen R&D and scale its distribution network. The move marks one of the more ambitious healthcare technology IPOs in recent times.
Breaking
positive
Integris Medtech files DRHP, eyes ₹3,500–4,000 crore IPO
about 3 hours ago
1 min read
72 words
Integris Medtech files DRHP for ₹3,500–4,000 crore IPO.
Integris Medtech, a diversified medical technology platform in India, has submitted its Draft Red Herring Prospectus (DRHP) to SEBI for an IPO. The company aims to raise between ₹3,500 and ₹4,000 crore, including a fresh issue portion. Backed by private equity firm Everstone, Integris plans to use proceeds to expand capacity, strengthen R&D and scale its distribution network. The move marks one of the more ambitious healthcare technology IPOs in recent times.
Integris Medtech, a diversified medical technology platform in India, has submitted its Draft Red Herring Prospectus (DRHP) to SEBI for an IPO. The company aims to raise between ₹3,500 and ₹4,000 crore, including a fresh issue portion. Backed by private equity firm Everstone, Integris plans to use proceeds to expand capacity, strengthen R&D and scale its distribution network. The move marks one of the more ambitious healthcare technology IPOs in recent times.
Companies:
Integris Medtech
Tags:
Integris Medtech
DRHP
Integris Medtech
DRHP
medical technology
IPO
healthcare
Source: